Cargando…

What to do in an oncology department to face the new COVID-19 era challenges?

Italy was the first European country to be hit by COVID-19 pandemic. As a consequence, Italian oncologists had to guarantee essential treatments although minimizing exposure to the virus, and accidental infection, of patients and healthcare professionals. As Department of Medical Oncology of the Uni...

Descripción completa

Detalles Bibliográficos
Autores principales: Garattini, S. K., Bin, A., Donato, R., Mansutti, M., Rizzato, S., Troiero, G., Candoni, A., Fanin, R., Fasola, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387254/
https://www.ncbi.nlm.nih.gov/pubmed/32728951
http://dx.doi.org/10.1007/s12032-020-01400-x
_version_ 1783564083653509120
author Garattini, S. K.
Bin, A.
Donato, R.
Mansutti, M.
Rizzato, S.
Troiero, G.
Candoni, A.
Fanin, R.
Fasola, G.
author_facet Garattini, S. K.
Bin, A.
Donato, R.
Mansutti, M.
Rizzato, S.
Troiero, G.
Candoni, A.
Fanin, R.
Fasola, G.
author_sort Garattini, S. K.
collection PubMed
description Italy was the first European country to be hit by COVID-19 pandemic. As a consequence, Italian oncologists had to guarantee essential treatments although minimizing exposure to the virus, and accidental infection, of patients and healthcare professionals. As Department of Medical Oncology of the University Hospital of Udine, in this short report, we describe the measures that we have taken, and gradually updated, since February 26, 2020. All accesses to our Oncology facilities are currently regulated by entrance check-points where patients are screened for infections following dedicated algorithms. Up to date, after 6 weeks of systematic execution of swabs no physician, nurse or other individual of the staff has been found positive to COVID-19. Only one patient admitted for therapy has been identified as COVID-19 positive. The aim of our work is to propose a model, made up of a set of operative procedures, that may be adopted by all the oncologists that daily struggle to guarantee safety and care in Oncology during this COVID-19 emergency.
format Online
Article
Text
id pubmed-7387254
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-73872542020-07-29 What to do in an oncology department to face the new COVID-19 era challenges? Garattini, S. K. Bin, A. Donato, R. Mansutti, M. Rizzato, S. Troiero, G. Candoni, A. Fanin, R. Fasola, G. Med Oncol Short Communication Italy was the first European country to be hit by COVID-19 pandemic. As a consequence, Italian oncologists had to guarantee essential treatments although minimizing exposure to the virus, and accidental infection, of patients and healthcare professionals. As Department of Medical Oncology of the University Hospital of Udine, in this short report, we describe the measures that we have taken, and gradually updated, since February 26, 2020. All accesses to our Oncology facilities are currently regulated by entrance check-points where patients are screened for infections following dedicated algorithms. Up to date, after 6 weeks of systematic execution of swabs no physician, nurse or other individual of the staff has been found positive to COVID-19. Only one patient admitted for therapy has been identified as COVID-19 positive. The aim of our work is to propose a model, made up of a set of operative procedures, that may be adopted by all the oncologists that daily struggle to guarantee safety and care in Oncology during this COVID-19 emergency. Springer US 2020-07-29 2020 /pmc/articles/PMC7387254/ /pubmed/32728951 http://dx.doi.org/10.1007/s12032-020-01400-x Text en © Springer Science+Business Media, LLC, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Short Communication
Garattini, S. K.
Bin, A.
Donato, R.
Mansutti, M.
Rizzato, S.
Troiero, G.
Candoni, A.
Fanin, R.
Fasola, G.
What to do in an oncology department to face the new COVID-19 era challenges?
title What to do in an oncology department to face the new COVID-19 era challenges?
title_full What to do in an oncology department to face the new COVID-19 era challenges?
title_fullStr What to do in an oncology department to face the new COVID-19 era challenges?
title_full_unstemmed What to do in an oncology department to face the new COVID-19 era challenges?
title_short What to do in an oncology department to face the new COVID-19 era challenges?
title_sort what to do in an oncology department to face the new covid-19 era challenges?
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387254/
https://www.ncbi.nlm.nih.gov/pubmed/32728951
http://dx.doi.org/10.1007/s12032-020-01400-x
work_keys_str_mv AT garattinisk whattodoinanoncologydepartmenttofacethenewcovid19erachallenges
AT bina whattodoinanoncologydepartmenttofacethenewcovid19erachallenges
AT donator whattodoinanoncologydepartmenttofacethenewcovid19erachallenges
AT mansuttim whattodoinanoncologydepartmenttofacethenewcovid19erachallenges
AT rizzatos whattodoinanoncologydepartmenttofacethenewcovid19erachallenges
AT troierog whattodoinanoncologydepartmenttofacethenewcovid19erachallenges
AT candonia whattodoinanoncologydepartmenttofacethenewcovid19erachallenges
AT faninr whattodoinanoncologydepartmenttofacethenewcovid19erachallenges
AT fasolag whattodoinanoncologydepartmenttofacethenewcovid19erachallenges